跳至主要内容
临床试验/NCT02090998
NCT02090998终止4 期

A Comparison of the Efficacy of 5% Lidocaine Anesthetic to Provide SPGB Vs. Elavil for the Treatment of Transformed Migraine

Rutgers, The State University of New Jersey2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2014年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
10
试验地点
2
主要终点
Number of Daily Headaches

研究概览

简要总结

This study will compare a local anesthetic technique that has been used to treat subjects suffering from transformed migraines (chronic migraines) versus medical management with traditional antidepressant Amitriptyline / Elavil.

Subjects will be randomized into one of two treatment groups to compare the safety and efficacy of the therapies. Subjects will recieve either sphenopalatine ganglion nerve block with 5% lidocaine gel into the nasopharynx or medical management with traditional antidepressants, Elavil, to produce a reduction in the frequency and severity of the headache.

We propose that there will be a difference in the outcomes when comparing the two methods of treating transformed migraines and that one research arm will result in more patient satisfaction and greater efficacy in the treatment of subjects

详细描述

Arm one will receive Sphenopalatine Ganglion Nerve Block weekly for 4 weeks

Arm two will receive Amitriptyline / Elavil daily for 30 Days

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female age 18-90
  • Subject have formal medical diagnosis of migraine headache
  • Subjects currently require treatment for headache
  • Subjects who have received optimal medical management from migraines including triptans (Imitrex, Amerge and Relpax)
  • Subjects who have recieved optimal medical management for migraines including anticonvulsants (Depakote, Lamictal, klonopin

排除标准

  • Less than 18 years of age
  • Subjects will be excluded if they are already being treated with lidocaine (patch or other vehicle) for chronic pain
  • Untreated Heart Failure
  • Individuals unwilling to comply with study procedures and follow-up

研究组 & 干预措施

SPG Nerve Block with Lidocaine 5% gel

Active Comparator

Sphenopalatine Ganglion Nerve Block (SPG Nerve Block) will be administed weekly for 4 weeks using 5% Lidocaine gel This intervention (a nerve block) will treat the headache for the time period investigated

干预措施: Amitriptyline (Drug)

Amitriptyline / Elavil

Active Comparator

Amitriptyline / Elavil 10 mg once a day for one week then Amitriotyline 20 mg once a day for three weeks This intervention will treat the headache for the time period investigated

干预措施: Amitriptyline (Drug)

SPG Nerve Block with Lidocaine 5% gel

Active Comparator

Sphenopalatine Ganglion Nerve Block (SPG Nerve Block) will be administed weekly for 4 weeks using 5% Lidocaine gel This intervention (a nerve block) will treat the headache for the time period investigated

干预措施: SPG Block with 5% Lidocaine gel (Procedure)

Amitriptyline / Elavil

Active Comparator

Amitriptyline / Elavil 10 mg once a day for one week then Amitriotyline 20 mg once a day for three weeks This intervention will treat the headache for the time period investigated

干预措施: SPG Block with 5% Lidocaine gel (Procedure)

结局指标

主要结局

Number of Daily Headaches

时间窗: Study Day 1 through Study Day 30

The number of times per day that symptoms occur

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

William Grubb, M.D.

Associate Prof.

Rutgers, The State University of New Jersey

研究点 (2)

Loading locations...

相似试验